Lista de obras - David B. Shultz - Dominio Público Uruguay

18F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy

artículo científico publicado en 2018

A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3.

artículo científico publicado en 2016

Activation of a Subset of Genes by IFN-γ Requires IKKβ but Not Interferon-Dependent Activation of NF-κB

article

An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report.

artículo científico publicado en 2017

Anatomic optimization of lung tumor stereotactic ablative radiation therapy

artículo científico publicado en 2015

Cognitive rehabilitation for executive dysfunction in brain tumor patients: a pilot randomized controlled trial

artículo científico publicado en 2019

Colorectal Histology Is Associated With an Increased Risk of Local Failure in Lung Metastases Treated With Stereotactic Ablative Radiation Therapy

artículo científico publicado en 2015

Cooperation of cytokine signaling with chimeric transcription factors in leukemogenesis: PML-retinoic acid receptor alpha blocks growth factor-mediated differentiation.

artículo científico publicado en 2003

Curability of patients with lymph node metastases from extremity soft-tissue sarcoma

scientific article published on 10 September 2020

Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.

artículo científico publicado en 2015

Early-Stage Non-Small Cell Lung Cancer: Quantitative Imaging Characteristics of (18)F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis

artículo científico publicado en 2016

Focal Leptomeningeal Disease with Perivascular Invasion in EGFR-Mutant Non-Small-Cell Lung Cancer

artículo científico publicado en 2020

Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response.

artículo científico publicado en 2014

Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy

artículo científico publicado en 2015

Hearing evaluation of patients with head and neck cancer: Comparison of Common Terminology Criteria for Adverse Events, Brock and Chang adverse event criteria in patients receiving cisplatin

artículo científico publicado en 2014

Hypofractionated Intensity-Modulated Radiotherapy for Patients With Non-Small-Cell Lung Cancer.

artículo científico publicado en 2016

Imaging features associated with disease progression after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer

artículo científico

Informational needs of brain metastases patients and their caregivers

scientific article published on 20 April 2018

Inhibitor of kappaB kinase is required to activate a subset of interferon gamma-stimulated genes.

artículo científico publicado en 2004

Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer.

artículo científico publicado en 2015

Long-term outcomes of surgery followed by radiation therapy for minor salivary gland carcinomas

artículo científico publicado en 2013

Management and Outcomes in the Oldest-Old Population with Glioblastoma

artículo científico publicado en 2017

Management of multiple meningiomas.

artículo científico

Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose

article

Postradiotherapy CA19-9 Kinetics Correlate With Outcomes in Patients With Pancreatic Adenocarcinoma

artículo científico publicado en 2014

Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR).

artículo científico publicado en 2016

Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity.

artículo científico publicado en 2007

Repeat Courses of Stereotactic Radiosurgery (SRS), Deferring Whole-Brain Irradiation, for New Brain Metastases After Initial SRS.

artículo científico publicado en 2015

Roles of IKK-beta, IRF1, and p65 in the activation of chemokine genes by interferon-gamma

artículo científico publicado en 2009

Should we expand the carbon ion footprint of prostate cancer?

artículo científico publicado en 2019

Sinoatrial node toxicity after stereotactic ablative radiation therapy to lung tumors

artículo científico publicado en 2017

Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer

artículo científico publicado en 2014

The Impact of Brain Metastases and Associated Neurocognitive Aspects on Health Utility Scores in EGFR Mutated and ALK Rearranged NSCLC: A Real World Evidence Analysis

scientific article published on 05 April 2019

The effect of arm position on the dosimetry of thoracic stereotactic ablative radiation therapy using volumetric modulated arc therapy

artículo científico publicado en 2013

The use of texture-based radiomics CT analysis to predict outcomes in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy

artículo científico publicado en 2018

The value of adaptive preoperative radiotherapy in management of soft tissue sarcoma

artículo científico publicado en 2017

Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors

artículo científico publicado en 2016

To SABR or not to SABR? Indications and contraindications for stereotactic ablative radiotherapy in the treatment of early-stage, oligometastatic, or oligoprogressive non-small cell lung cancer

artículo científico publicado en 2014

Vagal and recurrent laryngeal neuropathy following stereotactic ablative radiation therapy in the chest.

artículo científico publicado en 2013

Lista de obras de David B. Shultz

18F-EF5 PET-based Imageable Hypoxia Predicts Local Recurrence in Tumors Treated With Highly Conformal Radiation Therapy

A Novel Biomarker Panel Examining Response to Gemcitabine with or without Erlotinib for Pancreatic Cancer Therapy in NCIC Clinical Trials Group PA.3.

Activation of a Subset of Genes by IFN-γ Requires IKKβ but Not Interferon-Dependent Activation of NF-κB

An integrated multidisciplinary algorithm for the management of spinal metastases: an International Spine Oncology Consortium report.

Anatomic optimization of lung tumor stereotactic ablative radiation therapy

Cognitive rehabilitation for executive dysfunction in brain tumor patients: a pilot randomized controlled trial

Colorectal Histology Is Associated With an Increased Risk of Local Failure in Lung Metastases Treated With Stereotactic Ablative Radiation Therapy

Cooperation of cytokine signaling with chimeric transcription factors in leukemogenesis: PML-retinoic acid receptor alpha blocks growth factor-mediated differentiation.

Curability of patients with lymph node metastases from extremity soft-tissue sarcoma

Dosimetric Factors and Toxicity in Highly Conformal Thoracic Reirradiation.

Early-Stage Non-Small Cell Lung Cancer: Quantitative Imaging Characteristics of (18)F Fluorodeoxyglucose PET/CT Allow Prediction of Distant Metastasis

Focal Leptomeningeal Disease with Perivascular Invasion in EGFR-Mutant Non-Small-Cell Lung Cancer

Galectin-1 mediates radiation-related lymphopenia and attenuates NSCLC radiation response.

Gastrointestinal Toxicities With Combined Antiangiogenic and Stereotactic Body Radiation Therapy

Hearing evaluation of patients with head and neck cancer: Comparison of Common Terminology Criteria for Adverse Events, Brock and Chang adverse event criteria in patients receiving cisplatin

Hypofractionated Intensity-Modulated Radiotherapy for Patients With Non-Small-Cell Lung Cancer.

Imaging features associated with disease progression after stereotactic ablative radiotherapy for stage I non-small-cell lung cancer

Informational needs of brain metastases patients and their caregivers

Inhibitor of kappaB kinase is required to activate a subset of interferon gamma-stimulated genes.

Integrating Tumor and Stromal Gene Expression Signatures With Clinical Indices for Survival Stratification of Early-Stage Non-Small Cell Lung Cancer.

Long-term outcomes of surgery followed by radiation therapy for minor salivary gland carcinomas

Management and Outcomes in the Oldest-Old Population with Glioblastoma

Management of multiple meningiomas.

Outcomes following stereotactic radiosurgery for small to medium-sized brain metastases are exceptionally dependent upon tumor size and prescribed dose

Postradiotherapy CA19-9 Kinetics Correlate With Outcomes in Patients With Pancreatic Adenocarcinoma

Pre-treatment non-target lung FDG-PET uptake predicts symptomatic radiation pneumonitis following Stereotactic Ablative Radiotherapy (SABR).

Proinflammatory stimuli induce IKKalpha-mediated phosphorylation of PIAS1 to restrict inflammation and immunity.

Repeat Courses of Stereotactic Radiosurgery (SRS), Deferring Whole-Brain Irradiation, for New Brain Metastases After Initial SRS.

Roles of IKK-beta, IRF1, and p65 in the activation of chemokine genes by interferon-gamma

Should we expand the carbon ion footprint of prostate cancer?

Sinoatrial node toxicity after stereotactic ablative radiation therapy to lung tumors

Stereotactic ablative radiotherapy for pulmonary oligometastases and oligometastatic lung cancer

The Impact of Brain Metastases and Associated Neurocognitive Aspects on Health Utility Scores in EGFR Mutated and ALK Rearranged NSCLC: A Real World Evidence Analysis

The effect of arm position on the dosimetry of thoracic stereotactic ablative radiation therapy using volumetric modulated arc therapy

The use of texture-based radiomics CT analysis to predict outcomes in early-stage non-small cell lung cancer treated with stereotactic ablative radiotherapy

The value of adaptive preoperative radiotherapy in management of soft tissue sarcoma

Time course and predictive factors for lung volume reduction following stereotactic ablative radiotherapy (SABR) of lung tumors

To SABR or not to SABR? Indications and contraindications for stereotactic ablative radiotherapy in the treatment of early-stage, oligometastatic, or oligoprogressive non-small cell lung cancer

Vagal and recurrent laryngeal neuropathy following stereotactic ablative radiation therapy in the chest.